Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$447M |
| 2 |
STJ
St Jude Medical
STJ
|
+$321M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$281M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$276M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$556M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$411M |
| 3 |
ARG
Airgas Inc
ARG
|
+$314M |
| 4 |
US Bancorp
USB
|
+$187M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 3.42% |
| 2 | Energy | 2.84% |
| 3 | Technology | 2.82% |
| 4 | Healthcare | 2.45% |
| 5 | Consumer Discretionary | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
ImmunityBio
IBRX
$7.51B
| $91K | ﹤0.01% |
14,601
-2,480
| -15% | -$19.3K |
|
5052
Iovance Biotherapeutics
IOVA
$1.92B
| $91K | ﹤0.01% |
11,264
-32,413
| -74% | -$204K |
|
|
BCIC
5053
BCP Investment Corp
BCIC
$89.7M
| $91K | ﹤0.01% |
2,318
-270
| -10% | -$9.6K |
|
5054
TriplePoint Venture Growth BDC
TPVG
$188M
| $91K | ﹤0.01% |
8,597
+207
| +2% | +$2.18K |
|
5055
CALL
Warner Bros
WBD
$65.8B
| $91K | ﹤0.01% |
3,600
+3,200
| +800% | +$87.5K |
|
|
ABDC
5056
DELISTED
Alcentra Capital Corp
ABDC
| $91K | ﹤0.01% |
7,479
+353
| +5% | +$4.2K |
|
5057
Ceco Environmental
CECO
$3.93B
| $90K | ﹤0.01% |
10,266
-11,119
| -52% | -$82.6K |
|
|
FGB
5058
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
| $90K | ﹤0.01% |
14,735
+14,697
| +38,676% | +$89.7K |
|
5059
iShares Core MSCI EAFE ETF
IEFA
$191B
| $90K | ﹤0.01% |
1,738
+282
| +19% | +$15.1K |
|
5060
Preferred Bank
PFBC
$1.26B
| $90K | ﹤0.01% |
3,131
-8,567
| -73% | -$267K |
|
|
SF
5061
Stifel
SF
$12.6B
| $90K | ﹤0.01% |
6,412
-107,139
| -94% | -$1.59M |
|
5062
PUT
Toronto Dominion Bank
TD
$200B
| $90K | ﹤0.01% |
2,100
+200
| +11% | +$8.71K |
|
|
ONIT
5063
Onity Group
ONIT
$317M
| $90K | ﹤0.01% |
3,527
-8,791
| -71% | -$271K |
|
|
PTLA
5064
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $90K | ﹤0.01% |
3,816
-71,147
| -95% | -$1.76M |
|
|
SNOW
5065
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $90K | ﹤0.01% |
6,944
-36,846
| -84% | -$369K |
|
|
IBTX
5066
DELISTED
Independent Bank Group, Inc.
IBTX
| $90K | ﹤0.01% |
2,092
-6,564
| -76% | -$234K |
|
5067
AGCO
AGCO
$7.17B
| $89K | ﹤0.01% |
1,890
-2,905
| -61% | -$149K |
|
5068
Center Bancorp
CNOB
$1.69B
| $89K | ﹤0.01% |
5,687
-20,200
| -78% | -$326K |
|
5069
iShares MSCI New Zealand ETF
ENZL
$82.5M
| $89K | ﹤0.01% |
2,060
+15
| +0.7% | +$628 |
|
|
GLV
5070
Clough Global Dividend & Income Fund
GLV
$77.9M
| $89K | ﹤0.01% |
7,624
-4,754
| -38% | -$55.3K |
|
5071
Hurco Companies Inc
HURC
$139M
| $89K | ﹤0.01% |
3,206
-5,940
| -65% | -$187K |
|
5072
NACCO Industries
NC
$358M
| $89K | ﹤0.01% |
6,973
-11,747
| -63% | -$151K |
|
5073
Utah Medical Products
UTMD
$231M
| $89K | ﹤0.01% |
1,417
-1,723
| -55% | -$111K |
|
5074
Village Super Market
VLGEA
$648M
| $89K | ﹤0.01% |
3,069
-10,032
| -77% | -$263K |
|
|
SC
5075
PUT
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $89K | ﹤0.01% |
8,600
-231,700
| -96% | -$2.69M |
|
Similar funds
Citigroup's Q2 2016 Portfolio in Review
As of Q2 2016, Citigroup held 8,012 positions worth $98B, up 10% from $89B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup deployed $6.55B of net new capital in Q2 2016, opening 331 new positions and adding to 2,391 existing holdings. Its largest new stake was US Foods: 1,274,383 shares worth $30.9M.
By sector, the portfolio is most concentrated in Financials at 3.4% of assets, down from 4.2% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $556M trimmed.
- Citigroup's largest Q2 2016 buy was US Foods: 1,274,383 shares worth $30.9M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $447M increase.
- Citigroup's biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $556M.
- Citigroup fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $411M.
- Citigroup's ten largest holdings make up 30% of its $98B portfolio in Q2 2016.
- Citigroup opened 331 new positions and closed 861 in Q2 2016.
- Citigroup's portfolio value rose 10% quarter-over-quarter to $98B.
Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.